ADY Cash Flow Statement

Click line-items for a historical chart and %
Cash flows from operating activities:
Net income (loss) 10.56M
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
Depreciation of biological assets
Amortization of capital lease obligation 146.85K
Loss (gain) on disposal of property, plant and equipment
Loss on disposal of biological assets
Provision for (reversal of) doubtful accounts
Compensation expense for option awards 478.51K
Compensation expense from shares issued for services
Amortization of deferred charges
Changes in assets and liabilities:
(Increase) decrease in trade receivables, net 5.65M
Increase in due from related parties
Decrease in inventories, net 1.79M
Increase in advances to suppliers
Decrease in prepayments and other assets 6.43K
Decrease in income taxes receivable 0
Decrease in input value-added taxes
Increase in prepaid leases for land use rights
(Increase) decrease in other receivables -1.4M
(Increase) decrease in notes receivable
Increase (decrease) in notes payable -8.01M
(Decrease) increase in accrued expenses -3.46M
Increase in accounts payable 2.69M
Increase (decrease) in income taxes payable 243.71K
Decrease in advances from customers 1.08M
Increase in due to related parties 83.08K
Decrease in advances from employees
(Decrease) increase in employment benefits and salary payable 752.62K
(Decrease) increase in other payable -10.48M
Decrease in deferred income
(Decrease) increase in unrecognized tax benefit - non-current 167.17K
Net cash provided by operating activities 6.06M
Cash flows from investing activities:
Purchase of property, plant and equipment -4.87M
Expenditures on biological assets
Purchase of short term investment
Proceeds from disposal of property, plant and equipment 0
Payment for long term deposit
Change in restricted cash 6.63M
Proceeds from disposal of biological assets
Net cash used in investing activities -30.06M
Cash flows from financing activities:
Proceeds from short term bank loans 6.43M
Repayment of short term bank loans -8.03M
Proceeds from long term loans 0
Repayment of long term loans
Redemption of redeemable common stock
Proceeds from other long term loans
Capital injection in a new subsidiary by noncontrolling interests
Proceeds from option exercise
Net cash used in financing activities -1.61M
Effect of exchange rate changes on cash 78.09K
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period 40.43M
Cash and cash equivalents, end of period 14.89M
Supplemental disclosure of cash flow information:
Cash paid during the period for income tax
Cash received during the period for tax refund
Interest paid during the period
Supplemental disclosure of non-cash investing and financing activities:
Issuance of performance shares of common stock

Entities mentioned with ADY

View All Entities